Revolution Medicines

Organization

Biopharmaceutical company developing daraxonrasib and other RAS-targeting cancer therapies

2 stories

New Pancreatic Cancer Treatment Eliminates Tumors and Prevents Drug Resistance

New Treatment Strategy Eliminates Pancreatic Pre-Cancer Lesions